Assignee
HUTCHINSON FRED CANCER RES
US·191 granted patents·169 pending applications·5,666 citations·filing 1984–2025
Top patents by PatentIndex Score
360 records- 0197US10736918B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2017·Granted Aug 11, 2020·24 cites·30 claims
- 0297US6040177AHigh efficiency transduction of T lymphocytes using rapid expansion methods ("REM")HUTCHINSON FRED CANCER RES·Filed 1996·Granted Mar 21, 2000·593 cites·24 claims
- 0397US4861719ADNA constructs for retrovirus packaging cell linesHUTCHINSON FRED CANCER RES·Filed 1986·Granted Aug 29, 1989·707 cites·11 claims
- 0496US11441180B2Compositions and methods for accurately identifying mutationsHUTCHINSON FRED CANCER RES·Filed 2020·Granted Sep 13, 2022·29 cites·15 claims
- 0596US10780118B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2013·Granted Sep 22, 2020·21 cites·37 claims
- 0696US10011871B2Compositions and methods for accurately identifying mutationsHUTCHINSON FRED CANCER RES·Filed 2013·Granted Jul 3, 2018·43 cites·6 claims
- 0796US9809813B2Method of measuring adaptive immunityHUTCHINSON FRED CANCER RES·Filed 2016·Granted Nov 7, 2017·37 cites·9 claims
- 0896US5219740ARetroviral gene transfer into diploid fibroblasts for gene therapyHUTCHINSON FRED CANCER RES·Filed 1987·Granted Jun 15, 1993·947 cites·7 claims
- 0995US10869889B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2019·Granted Dec 22, 2020·8 cites·18 claims
- 1095US5827642ARapid expansion method ("REM") for in vitro propagation of T lymphocytesHUTCHINSON FRED CANCER RES·Filed 1994·Granted Oct 27, 1998·235 cites·11 claims
- 1193US10702551B2Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseHUTCHINSON FRED CANCER RES·Filed 2018·Granted Jul 7, 2020·6 cites·9 claims
- 1293US8349554B2Needle array assembly and method for delivering therapeutic agentsHUTCHINSON FRED CANCER RES·Filed 2008·Granted Jan 8, 2013·59 cites·45 claims
- 1393US8014957B2Genes associated with progression and response in chronic myeloid leukemia and uses thereofHUTCHINSON FRED CANCER RES·Filed 2006·Granted Sep 6, 2011·46 cites·16 claims
- 1493US6461807B1Methods for drug target screeningHUTCHINSON FRED CANCER RES·Filed 2000·Granted Oct 8, 2002·66 cites·36 claims
- 1592US10968275B2Anti-ROR1 antibodies and uses thereofHUTCHINSON FRED CANCER RES·Filed 2017·Granted Apr 6, 2021·17 cites·19 claims
- 1691US10822381B2Chlorotoxin variants, conjugates, and methods for their useHUTCHINSON FRED CANCER RES·Filed 2018·Granted Nov 3, 2020·3 cites·17 claims
- 1791US10392446B2Compositions and methods to modify cells for therapeutic objectivesHUTCHINSON FRED CANCER RES·Filed 2017·Granted Aug 27, 2019·4 cites·16 claims
- 1891US10350245B2Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2016·Granted Jul 16, 2019·21 cites·17 claims
- 1991US5002873ADNA sequence encoding a lymphocyte adhesion receptor for high endotheliumHUTCHINSON FRED CANCER RES·Filed 1989·Granted Mar 26, 1991·48 cites·12 claims
- 2090US11878029B2Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducersHUTCHINSON FRED CANCER RES·Filed 2021·Granted Jan 23, 2024·2 cites·13 claims
- 2190US9844563B2Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducersHUTCHINSON FRED CANCER RES·Filed 2017·Granted Dec 19, 2017·10 cites·14 claims
- 2290US7300755B1Methods for haplotyping genomic DNAHUTCHINSON FRED CANCER RES·Filed 2004·Granted Nov 27, 2007·42 cites·15 claims
- 2390US5879940AHuman marrow stromal cell lines which sustain hematopoiesesHUTCHINSON FRED CANCER RES·Filed 1997·Granted Mar 9, 1999·121 cites·12 claims
- 2490US4851511AMonoclonal antibody that specifically binds to disialosyl LeaHUTCHINSON FRED CANCER RES·Filed 1986·Granted Jul 25, 1989·77 cites·13 claims
- 2590US4614513AMethod and apparatus for treatment to remove immunoreactive substances from bloodHUTCHINSON FRED CANCER RES·Filed 1984·Granted Sep 30, 1986·79 cites·8 claims
- 2689US11078300B2Circular tandem repeat proteinsHUTCHINSON FRED CANCER RES·Filed 2020·Granted Aug 3, 2021·3 cites·20 claims
- 2789US11065278B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2018·Granted Jul 20, 2021·3 cites·11 claims
- 2889US10450606B2Compositions and methods for accurately identifying mutationsHUTCHINSON FRED CANCER RES·Filed 2016·Granted Oct 22, 2019·2 cites·25 claims
- 2989US10188749B2Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriersHUTCHINSON FRED CANCER RES·Filed 2017·Granted Jan 29, 2019·9 cites·8 claims
- 3089US9944683B2Chlorotoxin variants, conjugates, and methods for their useHUTCHINSON FRED CANCER RES·Filed 2012·Granted Apr 17, 2018·10 cites·23 claims
- 3189US7625704B2Methods and compositions for identifying bacteria associated with bacteria vaginosisHUTCHINSON FRED CANCER RES·Filed 2006·Granted Dec 1, 2009·70 cites·3 claims
- 3289US6165709AMethods for drug target screeningHUTCHINSON FRED CANCER RES·Filed 1998·Granted Dec 26, 2000·138 cites·41 claims
- 3388US11090358B2Cartilage-homing peptidesHUTCHINSON FRED CANCER RES·Filed 2016·Granted Aug 17, 2021·4 cites·27 claims
- 3488US10828333B2Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2019·Granted Nov 10, 2020·4 cites·20 claims
- 3588US10828352B2Compositions and methods for boosting the efficacy of adoptive cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2015·Granted Nov 10, 2020·6 cites·31 claims
- 3688US5604090AMethod for increasing transduction of cells by adeno-associated virus vectorsHUTCHINSON FRED CANCER RES·Filed 1994·Granted Feb 18, 1997·113 cites·30 claims
- 3787US10494434B2Tagged chimeric effector molecules and receptors thereofHUTCHINSON FRED CANCER RES·Filed 2014·Granted Dec 3, 2019·10 cites·31 claims
- 3887US10370643B2LILRB2 and notch-mediated expansion of hematopoietic precursor cellsHUTCHINSON FRED CANCER RES·Filed 2015·Granted Aug 6, 2019·5 cites·19 claims
- 3987US7399633B2Methods for immortalizing cellsHUTCHINSON FRED CANCER RES·Filed 2001·Granted Jul 15, 2008·47 cites·8 claims
- 4087US5795723AExpression of neurogenic bHLH genes in primitive neuroectodermal tumorsHUTCHINSON FRED CANCER RES·Filed 1997·Granted Aug 18, 1998·58 cites·6 claims
- 4187US2025195556A1Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducersHUTCHINSON FRED CANCER RES·Filed 2024·Application pending·0 cites
- 4286US11116835B2Epstein Barr virus antibodies, vaccines, and uses of the sameHUTCHINSON FRED CANCER RES·Filed 2018·Granted Sep 14, 2021·5 cites·20 claims
- 4386US11046766B2Tagged chimeric effector molecules and receptors thereofHUTCHINSON FRED CANCER RES·Filed 2019·Granted Jun 29, 2021·2 cites·34 claims
- 4486US4894326AMonoclonal antibody defining oncofetal structure of fibronectinHUTCHINSON FRED CANCER RES·Filed 1986·Granted Jan 16, 1990·60 cites·16 claims
- 4585US11235076B2Chelating platform for delivery of radionuclidesHUTCHINSON FRED CANCER RES·Filed 2017·Granted Feb 1, 2022·5 cites·21 claims
- 4685US11034748B2High affinity MAGE-A1-specific TCRs and uses thereofHUTCHINSON FRED CANCER RES·Filed 2019·Granted Jun 15, 2021·4 cites·30 claims
- 4785US10653756B2Identification of CD8+ T cells that are CD161hi and/or IL18R(α)hi and have rapid drug efflux capacityHUTCHINSON FRED CANCER RES·Filed 2018·Granted May 19, 2020·2 cites·15 claims
- 4885US10639321B2Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducersHUTCHINSON FRED CANCER RES·Filed 2015·Granted May 5, 2020·2 cites·19 claims
- 4985US7615350B2Methods for haplotyping genomic DNAHUTCHINSON FRED CANCER RES·Filed 2007·Granted Nov 10, 2009·4 cites·12 claims
- 5085US5958769ACompositions and methods for mediating cell cycle progressionHUTCHINSON FRED CANCER RES·Filed 1996·Granted Sep 28, 1999·84 cites·20 claims
Showing the top 50 of 360 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when HUTCHINSON FRED CANCER RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →